financetom
Business
financetom
/
Business
/
Archimed to take Esperion Therapeutics private for up to $1.1 billion
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Archimed to take Esperion Therapeutics private for up to $1.1 billion
May 1, 2026 4:21 AM

May 1 (Reuters) - Investment firm Archimed said on

Friday it will take drug developer Esperion Therapeutics ( ESPR )

private for up to $1.1 billion.

(Reporting by Sriparna Roy in Bengaluru)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Copyright 2023-2026 - www.financetom.com All Rights Reserved